Ministry also specified 20 comorbidities among people aged between 45 and 59 years who will get the vaccine
On February 19, Dr Reddy's Laboratories said it had approached drugs regulator DCGI for emergency use authorisation (EUA) for the Russian vaccine.
Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, he add
The results of the analysis from a phase 3 randomised controlled trial, published in The Lancet journal, suggest that the interval between doses can b
India is playing a central role in global vaccination and the country's vision for wellness is as much global as it is domestic, says PM
The government is taking feedback from those vaccinated since January 17
The South African strain spreads more rapidly
Additional order placed on Serum Institute and Bharat Biotech